China Cord Blood Corporation to Report Third Quarter and First Nine Months of Fiscal 2014 Financial Results
Earnings Call Scheduled for 8:00 a.m. ET on February 25, 2014
HONG KONG, Feb. 17, 2014 /PRNewswire-FirstCall/ — China Cord Blood Corporation (NYSE: CO) (the “Company”) today announced its plan to release financial results for the third quarter and first nine months of fiscal year 2014 on Monday, February 24, 2014, after the markets close in the U.S.
The Company will host a conference call at 8:00 a.m. ET on Tuesday, February 25, 2014 to discuss its financial performance and give a brief overview of the Company’s recent developments, followed by a question and answer session. Interested parties may access the audio webcast through the Company’s IR website at http://ir.chinacordbloodcorp.com. A replay of the webcast will be accessible two hours after the conference call and available for three weeks at the same URL link above. Listeners may also access the call by dialing 1-631-514-2526 or 1-855-298-3404 for US callers or +852-5808-3202 for Hong Kong callers, access code: 2926250.
Please dial in ten minutes prior to the conference call to ensure proper connection, and be prepared to provide your name and company name to the operator.
Supplemental financial information referenced in the conference call and the third quarter of fiscal 2014 earnings press release will be available at http://www.chinacordbloodcorp.com, in the section titled Investor Center/Press Release, after 4:00 p.m. ET on Monday, February 24, 2014 and in the Company’s Report on Form 6-K for the month of February 2014 available on the Securities and Exchange Commission’s website at www.sec.gov.
About China Cord Blood Corporation
China Cord Blood Corporation is the first and largest umbilical cord blood banking operator in China in terms of geographical coverage and the only cord blood banking operator with multiple licenses. Under current PRC government regulations, only one licensed cord blood banking operator is permitted to operate in each licensed region and only seven licenses have been authorized as of today. China Cord Blood Corporation provides cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. For more information, please visit the Company’s website at http://www.chinacordbloodcorp.com.
For more information, please contact:
China Cord Blood Corporation
Investor Relations Department
Tel: (+852) 3605-8180
Mr. William Zima
Tel: (+86) 10-6583-7511
U.S. Tel: (646) 405-5185
SOURCE China Cord Blood Corporation